Nephrocare Health Se
Ticker > Company >

Nephrocare Health Se share price

Nephrocare Health Services Ltd.

NSE: NEPHROPLUS BSE: 544647 SECTOR: Hospital & Healthcare Services  75   0   0

473.00
+1.75 (0.37%)
NSE: Today, 10:34 AM

Price Summary

Today's High

₹ 478.5

Today's Low

₹ 466

52 Week High

₹ 499

52 Week Low

₹ 463.8

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 4746.12 Cr.

Enterprise Value

₹ 4835.72 Cr.

No. of Shares

10.03 Cr.

P/E

138.63

P/B

5.3

Face Value

₹ 2

Div. Yield

0 %

Book Value (TTM)

₹  89.32

CASH

₹ 33.42 Cr.

DEBT

₹ 123.03 Cr.

Promoter Holding

-

EPS (TTM)

₹  3.41

Sales Growth

24.61%

ROE

7.44 %

ROCE

9.56%

Profit Growth

781.92 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year24.61%
3 YearNA
5 YearNA

Profit Growth

1 Year781.92%
3 YearNA
5 YearNA

ROE%

1 Year7.44%
3 Year1.47%

ROCE %

1 Year9.56%
3 Year4.27%

Debt/Equity

0.2324

Price to Cash Flow

59.53

Interest Cover Ratio

4.1722

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Investors List
 Share Holding Data is not available for this company.Report us
* Figures given above are % of equity capital

 Strengths

  • The company has significantly decreased its debt by 55.396 Cr.
  • Company’s PEG ratio is 0.1791245193729.
  • The company has an efficient Cash Conversion Cycle of -1.11490000000001 days.
  • Company has a healthy liquidity position with current ratio of 2.1385.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 21.1890177460458.

 Limitations

  • The company has shown a poor profit growth of 0% for the Past 3 years.
  • The company has shown a poor revenue growth of 0% for the Past 3 years.
  • Company has a poor ROE of 1.47363333333333% over the past 3 years.
  • Company has a poor ROCE of 4.2748% over the past 3 years
  • The company has a low EBITDA margin of 0% over the past 5 years.
  • The company is trading at a high EV/EBITDA of 43.3026.

Quarterly Result (All Figures in Cr.)
 Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2023 Mar 2024 Mar 2025
Net Sales 386.11 436.23 543.6
Total Expenditure 348.15 384.27 448.71
Operating Profit 37.97 51.96 94.88
Other Income 5.09 7.8 15.63
Interest 15.03 16.82 14.3
Depreciation 40.91 42.73 50.86
Exceptional Items 0 0 0
Profit Before Tax -12.88 0.22 45.36
Tax 2.59 -3.67 11.12
Net Profit -15.47 3.88 34.24
Adjusted EPS (Rs.) -17.78 4.44 38.79

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 5.14 5.14 5.43
Total Reserves 391.51 399.07 536.58
Borrowings 81.48 63.95 45.9
Other N/C liabilities -5.35 -9.37 -4.18
Current liabilities 156.85 185.03 154.9
Total Liabilities 629.63 643.83 738.63
Assets
Net Block 168.51 218.64 233.97
Capital WIP 0.44 0.69 4.3
Intangible WIP 2.19 0 0
Investments 147.93 148.57 161.6
Loans & Advances 9.32 15.75 6.32
Other N/C Assets 18.65 3.63 1.18
Current Assets 282.59 256.55 331.25
Total Assets 629.63 643.83 738.63
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2023 Mar 2024 Mar 2025
Profit from operations -12.88 0.22 45.36
Adjustment 57.45 64 60.86
Changes in Assets & Liabilities -37.38 -1.66 -29.92
Tax Paid 3.95 -5.81 3.43
Operating Cash Flow 11.14 56.75 79.73
Investing Cash Flow -74.71 -22.67 -103.52
Financing Cash Flow 63.39 -35.54 26.02
Net Cash Flow -0.18 -1.46 2.23

Corporate Actions

Investors Details

 No Promoters Data available for this company.Report us
 No Investors Data available for this company.Report us

Annual Reports

Title Link
Title Link
 No Annual reports exist for this company.Report us

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit and Research reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation and Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us
Last Updated on:
Brief about Nephrocare Health Se

Nephrocare Health Services Share Price, Business Overview & News

Nephrocare Health Services Limited, widely recognised by its brand NephroPlus, made its debut on the Indian stock exchanges today, December 17, 2025. As India's largest network of dialysis centers, the company has established itself as a critical player in the renal care ecosystem. The stock listed at a premium, reflecting positive investor sentiment towards its dominant market position and scalable service model.

Nephrocare Health Services Share Price & Listing Performance

Nephrocare Health Services shares listed on the NSE today at Rs 490, marking a premium of 6.52% over its IPO issue price of Rs 460. The listing aligns with the steady demand seen during its subscription phase and the stable Grey Market Premium (GMP) leading up to the debut.

  • Listing Date: December 17, 2025

  • IPO Issue Price: Rs 460 per share

  • Listing Price: Rs 490 per share (NSE)

  • Intraday High: Track live on the chart above.

  • Market Cap: Approx. Rs 4,900 Crore+ (based on listing price)

Note: For the latest Nephrocare Health Services share price, charts, and volume data, please refer to the live data section at the top of this page.

The Business of Nephrocare Health Services: How It Earns

Nephrocare Health Services operates under the brand NephroPlus, focusing exclusively on providing high-quality dialysis services. It has pioneered a unique "dialysis-as-a-service" model in India, partnering with hospitals to manage their dialysis units.

  • Core Business Model: The company operates on a revenue-sharing or fixed-fee model with partner hospitals. By taking over the operations, equipment, and staffing of dialysis centers, NephroPlus ensures standardised care while reducing the administrative burden on hospitals.

  • Network & Scale: It runs India’s largest network of dialysis centers, serving thousands of chronic kidney disease (CKD) patients daily. The network spans across metros, Tier-2, and Tier-3 cities, ensuring accessibility to life-saving treatments.

  • Revenue Drivers:

    • Dialysis Sessions: The primary revenue source is the fee charged per dialysis session, often covered by private insurance or government health schemes (like PMJAY).

    • Ancillary Services: Revenue is also generated from related services such as fistula procedures, catheterisations, and pharmacy sales within its centers.

    • International Presence: The company has also expanded its footprint internationally, with centers in markets like the Philippines and Uzbekistan, diversifying its revenue streams.

Major News & Developments

  • IPO Success: The Nephrocare Health Services IPO, which closed on December 12, 2025, raised a total of Rs 871.05 Crore. The issue comprised a fresh issue of Rs 353.40 Crore and an Offer for Sale (OFS) of Rs 517.64 Crore.

  • Fund Utilisation: The net proceeds from the fresh issue will be utilised for:

    • Network Expansion: Setting up new dialysis centers across India and select international markets.

    • Medical Equipment: Upgrading existing infrastructure with advanced hemodialysis machines.

    • Marketing & Branding: Increasing awareness about kidney health and the NephroPlus brand.

  • Anchor Investment: Prior to the public issue, the company successfully raised Rs 260.26 Crore from marquee anchor investors, signalling strong institutional confidence in its business fundamentals.

What You Can Find on This Company Page

This page is your comprehensive resource for tracking Nephrocare Health Services Limited.

  • Live Share Price: Real-time BSE/NSE quotes, percentage change, and volume.

  • Financials: Quarterly results, profit & loss statements, and key ratios (P/E, EBITDA margins).

  • Shareholding Pattern: Updates on promoter holdings and institutional participation post-listing.

  • Peer Comparison: Compare Nephrocare's valuation with other healthcare service providers like Apollo Hospitals and Max Healthcare.

Frequently Asked Questions (FAQs)

What is the current share price of Nephrocare Health Services?

The live share price is available at the top of this page. The stock listed on December 17, 2025, at Rs 490 on the NSE.

What does Nephrocare Health Services do?

Nephrocare Health Services, operating as NephroPlus, is a leading provider of dialysis services. It partners with hospitals to set up and manage dialysis centers, offering standardised and high-quality renal care to patients.

When did Nephrocare Health Services list?

The company’s shares were listed on the BSE and NSE on December 17, 2025.

Is NephroPlus a profitable company?

You can view the detailed financial statements and profit/loss trends in the "Financials" tab on this page to assess the company's profitability and growth trajectory

What was the issue price of the Nephrocare Health IPO?

The IPO price band was Rs 438 – Rs 460 per share, and the shares were issued at the upper band of Rs 460.

Read More
X